MARKET

CNCR

CNCR

Loncar Cancer Immunotherapy ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

28.79
-0.52
-1.77%
Opening 14:02 05/06 EDT
OPEN
29.25
PREV CLOSE
29.31
HIGH
29.25
LOW
28.79
VOLUME
2.35K
TURNOVER
--
52 WEEK HIGH
35.82
52 WEEK LOW
23.09
TOTAL ASSET
44.58M
YTD YIELD
7.47%
1D
5D
1M
3M
1Y
5Y
Best Biotech Stocks & ETFs for mRNA, Gene Editing
Zacks.com · 6d ago
How To Pick The Best ETF
Investopedia · 03/15 23:06
Fallen-Angel ETF Doubles to $1 Billion as ‘Covid Discount’ Fades
Bloomberg · 01/20 16:11
Vanguard Signals Fee War Intensifies With Active Bond ETF Plan
Bloomberg · 01/20 12:49
Big Oil Takes Unsteady Steps to Cut Transition Risk
For the least prepared in a low-carbon economy, the verdict is in.
Bloomberg · 01/20 11:00
China ETF Overtakes BlackRock Fund as Investors Avert Sanctions
A Chinese exchange-traded fund has surpassed BlackRock’s Inc.’s ETF to become the largest tracking onshore stocks as investors look to ride a surge in equities while skirting a U.S. clampdown.
Bloomberg · 01/20 08:32
Credit ETFs Cause a Liquidity Problem and Then Sell the Solution
Wall Street’s long-running debate over whether corporate bond ETFs are either a force for good or bad might be missing the point. Both sides are likely right.
Bloomberg · 01/19 14:23
Options Feedback Loop Revives Bust Warnings in Soaring Stocks
As stocks extend their relentless rally from last year’s bottom, one measure in the options market is flashing a warning signal.
Bloomberg · 01/14 15:57
More
No Data
Learn about the latest financial forecast of CNCR. Analyze the recent business situations of Loncar Cancer Immunotherapy ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-4.0735%
--
1-Week
-3.3595%
--
1-Month
-5.0143%
--
3-Month
-4.7065%
--
6-Month
14.1693%
--
YTD
7.4707%
--
1-Year
32.4268%
--
3-Year
-0.4919%
--
Since Inception
0.5594%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
Loncar Cancer Immunotherapy ETF
Risk
Low risk
Inception Date
2015-10-13
Benchmark
Dow Jones US Healthcare TR
Advisor Company
Loncar Investments
Custodian
U.S. Bank N.A
Manager
Wen/Zayas